Form 1 survey screenshot

Generic Clearance for the Collection of Qualitative Feedback on Agency Service Delivery (NIH)

HPV_Cancer_Center_Consortium_Survey FINAL

HPV Cancer Center Consortium Survey (NCI)

OMB: 0925-0648

Document [docx]
Download: docx | pdf



HPV Cancer Center Consortium



Start of Block: Block 1


OMB No.: 0925-0648

Expiration Date: 06/30/2024


Public reporting burden for this collection of information is estimated to average 10 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering, and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0648). Do not return the completed form to this address.


The goal of this survey is to assess interest in participating in future HPV Cancer Center Consortium activities and meetings and to identify topics of greatest interest. Please feel free to share this survey with others who may have an interest in HPV vaccination uptake.





How would you describe your professional role?*

  • Researcher

  • Clinician

  • Public health practitioner

  • Funding agency partner

  • Other




Display This Question:

If How would you describe your professional role?* = Other


Please describe your professional role

________________________________________________________________





Did you attend the February 2023 meeting?*

  • Yes

  • No




Display This Question:

If Did you attend the February 2023 meeting?* = Yes


How helpful or informative were the following sessions in understanding HPV vaccination uptake?


Not at all helpful/informative

Somewhat helpful/informative

Extremely helpful/informative

Did not attend

History and Recap of the HPV Cancer Center Consortium

Updates on National Immunization Survey-Teen HPV Vaccination Coverage

Consequences of COVID-19 for HPV Vaccine Implementation

Lessons Learned from Other Consortiums



End of Block: Block 1


Start of Block: Block 2


As we start to plan for the Fall 2023 meeting: 





What topics would you like to see addressed?

________________________________________________________________





What would be your preferred meeting schedule?

  • 2 half-days with dinner on Day 1

  • 1 full day with dinner the night before

  • 1 full day with dinner the night of the meeting





What meeting format do you prefer for Fall 2023?

______ In-person

______ Virtual

______ Hybrid


End of Block: Block 2


Start of Block: Block 3


In order to help advance the Consortium:





What goals and objectives should the Consortium work towards?

________________________________________________________________





Who else would benefit from joining the Consortium?

________________________________________________________________





What support, collaborations, and resources are needed in order to enable participants to keep the momentum on Consortium action plans?

________________________________________________________________





Are you interested in leading any Consortium activities?*

  • Yes

  • No





Would you like to receive information about related Consortium webinars, initiatives, and activities?

  • Yes

  • No


End of Block: Block 3


Start of Block: Block 4


For internal use only, please provide:





First and last name*

________________________________________________________________





Email address*

________________________________________________________________


End of Block: Block 4



Page 6 of 6


File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File TitleHPV Cancer Center Consortium
AuthorQualtrics
File Modified0000-00-00
File Created2023-08-26

© 2024 OMB.report | Privacy Policy